Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 45

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 45
---
) Consists of (i) 125,909 shares of our common stock held by Mr. Stapley, and (ii) options to purchase 286,539 shares of our common stock held by Mr. Stapley that are exercisable within 60 days of March 31, 2025.

(8) Consists of (i) 38,712 shares of our common stock held by Ms. Chambers, and (ii) options to purchase 150,832 shares of our common stock held by Ms. Chambers that are exercisable within 60 days of March 31, 2025.

(9) Consists of (i) 16,048 shares of our common stock held by Dr. Febbo, and (ii) options to purchase 33,985 shares of our common stock held by Dr. Febbo that are exercisable within 60 days of March 31, 2025.

(10) Consists of (i) 8,521 shares of our common stock held by Dr. Leite, and (ii) options to purchase 42,382 shares of our common stock held by Dr. Leite that are exercisable within 60 days of March 31, 2025

(11) Consists of (i) 13,693 shares of our common stock held by Ms. McGuire, and (ii) options to purchase 71,055 shares of our common stock held by Ms. McGuire that are exercisable within 60 days of March 31, 2025.

(12) Consists of (i) 23,488 shares of our common stock held by Dr. Barr.

(13) Consists of (i) 23,105 shares of our common stock held by Ms. Bhanji.

#### Veracyte2025 Proxy Statement41
Security Ownership of Certain Beneficial Owners and Management

(14) Consists of (i) 7,024 shares of our common stock held by Ms. Eastham, and (ii) options to purchase 40,000 shares of our common stock held by Ms. Eastham that are exercisable within 60 days of March 31, 2025.

(15) Consists of (i) 53,125 shares of our common stock held by Dr. Epstein, and (ii) options to purchase 40,000 shares of our common stock held by Dr. Epstein that are exercisable within 60 days of March 31, 2025.